162 related articles for article (PubMed ID: 22368149)
1. Effect of PON1 Q192R genetic polymorphism on clopidogrel efficacy and cardiovascular events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events trial and the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events.
Paré G; Ross S; Mehta SR; Yusuf S; Anand SS; Connolly SJ; Fox KA; Eikelboom JW
Circ Cardiovasc Genet; 2012 Apr; 5(2):250-6. PubMed ID: 22368149
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase-1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placement.
Trenk D; Hochholzer W; Fromm MF; Zolk O; Valina CM; Stratz C; Neumann FJ
Circ Cardiovasc Genet; 2011 Aug; 4(4):429-36. PubMed ID: 21685174
[TBL] [Abstract][Full Text] [Related]
3. PON1 Q192R genotype influences clopidogrel responsiveness by relative platelet inhibition instead of on-treatment platelet reactivity.
Li X; Zhang L; Chen X; Qu F; Li J; Ma C; Yang J; Xu B; Wang H; Xu Q; Zhang Y; Li Y; Lu C; Yin T
Thromb Res; 2013 Oct; 132(4):444-9. PubMed ID: 23993903
[TBL] [Abstract][Full Text] [Related]
4. Effect of paraoxonase-1 polymorphism on clinical outcomes in patients treated with clopidogrel after an acute myocardial infarction.
Simon T; Steg PG; Becquemont L; Verstuyft C; Kotti S; Schiele F; Ferrari E; Drouet E; Grollier G; Danchin N
Clin Pharmacol Ther; 2011 Oct; 90(4):561-7. PubMed ID: 21918510
[TBL] [Abstract][Full Text] [Related]
5. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.
Mehta SR; Yusuf S;
Eur Heart J; 2000 Dec; 21(24):2033-41. PubMed ID: 11102254
[TBL] [Abstract][Full Text] [Related]
6. CYP2C19 but not PON1 genetic variants influence clopidogrel pharmacokinetics, pharmacodynamics, and clinical efficacy in post-myocardial infarction patients.
Hulot JS; Collet JP; Cayla G; Silvain J; Allanic F; Bellemain-Appaix A; Scott SA; Montalescot G
Circ Cardiovasc Interv; 2011 Oct; 4(5):422-8. PubMed ID: 21972404
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonase 1 Q192R variant and clopidogrel efficacy: fact or fiction?
Lewis JP; Shuldiner AR
Circ Cardiovasc Genet; 2012 Apr; 5(2):153-5. PubMed ID: 22511706
[No Abstract] [Full Text] [Related]
8. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
[TBL] [Abstract][Full Text] [Related]
9. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
Peters RJ; Mehta SR; Fox KA; Zhao F; Lewis BS; Kopecky SL; Diaz R; Commerford PJ; Valentin V; Yusuf S;
Circulation; 2003 Oct; 108(14):1682-7. PubMed ID: 14504182
[TBL] [Abstract][Full Text] [Related]
10. PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes.
Mega JL; Close SL; Wiviott SD; Man M; Duvvuru S; Walker JR; Sundseth SS; Collet JP; Delaney JT; Hulot JS; Murphy SA; Paré G; Price MJ; Sibbing D; Simon T; Trenk D; Antman EM; Sabatine MS
J Thromb Thrombolysis; 2016 Apr; 41(3):374-83. PubMed ID: 26573179
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase-1 Q192R polymorphism is not associated with clopidogrel response in Chinese stroke patients.
Yang J; Zhou JS; Tan J; He BS; Zou JJ
Pharmazie; 2012 Dec; 67(12):1026-9. PubMed ID: 23346768
[TBL] [Abstract][Full Text] [Related]
12. Effects of CYP2C19 genotype on outcomes of clopidogrel treatment.
Paré G; Mehta SR; Yusuf S; Anand SS; Connolly SJ; Hirsh J; Simonsen K; Bhatt DL; Fox KA; Eikelboom JW
N Engl J Med; 2010 Oct; 363(18):1704-14. PubMed ID: 20979470
[TBL] [Abstract][Full Text] [Related]
13. Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
Lewis BS; Mehta SR; Fox KA; Halon DA; Zhao F; Peters RJ; Keltai M; Budaj A; Yusuf S;
Am Heart J; 2005 Dec; 150(6):1177-84. PubMed ID: 16338255
[TBL] [Abstract][Full Text] [Related]
14. Renal function and outcomes in acute coronary syndrome: impact of clopidogrel.
Keltai M; Tonelli M; Mann JF; Sitkei E; Lewis BS; Hawken S; Mehta SR; Yusuf S;
Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):312-8. PubMed ID: 17446813
[TBL] [Abstract][Full Text] [Related]
15. Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis.
Reny JL; Combescure C; Daali Y; Fontana P;
J Thromb Haemost; 2012 Jul; 10(7):1242-51. PubMed ID: 22520065
[TBL] [Abstract][Full Text] [Related]
16. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ;
J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.
Kovács TJ; Harris S; Vas TK; Seres I; Short CD; Wittmann IK; Paragh G; Mackness MI; Mackness B; Durrington PN; Nagy JM; Brenchley PE
J Nephrol; 2006; 19(6):732-8. PubMed ID: 17173245
[TBL] [Abstract][Full Text] [Related]
18. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial.
Held C; Asenblad N; Bassand JP; Becker RC; Cannon CP; Claeys MJ; Harrington RA; Horrow J; Husted S; James SK; Mahaffey KW; Nicolau JC; Scirica BM; Storey RF; Vintila M; Ycas J; Wallentin L
J Am Coll Cardiol; 2011 Feb; 57(6):672-84. PubMed ID: 21194870
[TBL] [Abstract][Full Text] [Related]
19. Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm.
Ito T; Yasue H; Yoshimura M; Nakamura S; Nakayama M; Shimasaki Y; Harada E; Mizuno Y; Kawano H; Ogawa H
Hum Genet; 2002 Jan; 110(1):89-94. PubMed ID: 11810302
[TBL] [Abstract][Full Text] [Related]
20. Association between Paraoxonase-1 p.Q192R Polymorphism and Coronary Artery Disease susceptibility in the Colombian Population.
Corredor-Orlandelli D; Sambracos-Parrado S; Mantilla-García S; Tovar-Tirado J; Vega-Ramírez V; Mendoza-Ayús SD; Peña LC; Leal MF; Rodríguez-Carrillo J; León-Torres J; Pardo-Oviedo JM; Parra Abaunza K; Contreras Bravo NC; Ortega-Recalde O; Fonseca Mendoza DJ
Vasc Health Risk Manag; 2021; 17():689-699. PubMed ID: 34764653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
